S&P 500   4,374.23 (+1.10%)
DOW   34,321.28 (+0.47%)
QQQ   346.41 (+1.56%)
AAPL   167.49 (+5.19%)
MSFT   304.09 (+1.42%)
FB   298.44 (+1.29%)
GOOGL   2,637.14 (+2.21%)
AMZN   2,811.39 (+0.67%)
TSLA   847.65 (+2.24%)
NVDA   222.09 (+1.21%)
BABA   112.58 (+0.71%)
NIO   20.82 (-1.37%)
AMD   103.33 (+0.71%)
CGC   7.22 (+5.40%)
MU   77.44 (-1.63%)
GE   90.47 (+0.63%)
T   24.53 (+1.70%)
F   19.40 (-0.77%)
DIS   135.79 (+0.27%)
AMC   14.53 (+0.07%)
PFE   54.46 (+2.04%)
ACB   3.91 (+3.17%)
BA   188.23 (-0.80%)
S&P 500   4,374.23 (+1.10%)
DOW   34,321.28 (+0.47%)
QQQ   346.41 (+1.56%)
AAPL   167.49 (+5.19%)
MSFT   304.09 (+1.42%)
FB   298.44 (+1.29%)
GOOGL   2,637.14 (+2.21%)
AMZN   2,811.39 (+0.67%)
TSLA   847.65 (+2.24%)
NVDA   222.09 (+1.21%)
BABA   112.58 (+0.71%)
NIO   20.82 (-1.37%)
AMD   103.33 (+0.71%)
CGC   7.22 (+5.40%)
MU   77.44 (-1.63%)
GE   90.47 (+0.63%)
T   24.53 (+1.70%)
F   19.40 (-0.77%)
DIS   135.79 (+0.27%)
AMC   14.53 (+0.07%)
PFE   54.46 (+2.04%)
ACB   3.91 (+3.17%)
BA   188.23 (-0.80%)
S&P 500   4,374.23 (+1.10%)
DOW   34,321.28 (+0.47%)
QQQ   346.41 (+1.56%)
AAPL   167.49 (+5.19%)
MSFT   304.09 (+1.42%)
FB   298.44 (+1.29%)
GOOGL   2,637.14 (+2.21%)
AMZN   2,811.39 (+0.67%)
TSLA   847.65 (+2.24%)
NVDA   222.09 (+1.21%)
BABA   112.58 (+0.71%)
NIO   20.82 (-1.37%)
AMD   103.33 (+0.71%)
CGC   7.22 (+5.40%)
MU   77.44 (-1.63%)
GE   90.47 (+0.63%)
T   24.53 (+1.70%)
F   19.40 (-0.77%)
DIS   135.79 (+0.27%)
AMC   14.53 (+0.07%)
PFE   54.46 (+2.04%)
ACB   3.91 (+3.17%)
BA   188.23 (-0.80%)
S&P 500   4,374.23 (+1.10%)
DOW   34,321.28 (+0.47%)
QQQ   346.41 (+1.56%)
AAPL   167.49 (+5.19%)
MSFT   304.09 (+1.42%)
FB   298.44 (+1.29%)
GOOGL   2,637.14 (+2.21%)
AMZN   2,811.39 (+0.67%)
TSLA   847.65 (+2.24%)
NVDA   222.09 (+1.21%)
BABA   112.58 (+0.71%)
NIO   20.82 (-1.37%)
AMD   103.33 (+0.71%)
CGC   7.22 (+5.40%)
MU   77.44 (-1.63%)
GE   90.47 (+0.63%)
T   24.53 (+1.70%)
F   19.40 (-0.77%)
DIS   135.79 (+0.27%)
AMC   14.53 (+0.07%)
PFE   54.46 (+2.04%)
ACB   3.91 (+3.17%)
BA   188.23 (-0.80%)
Positive News Sentiment  
NYSE:RCOR

Renovacor Stock Forecast, Price & News

$6.42
-0.05 (-0.77%)
(As of 01/27/2022 12:00 AM ET)
Add
Compare
Today's Range
$6.07
▼
$6.92
50-Day Range
$6.45
▼
$9.39
52-Week Range
$5.21
▼
$11.12
Volume
16,545 shs
Average Volume
33,636 shs
Market Capitalization
$110.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-0.41
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive RCOR News and Ratings via Email

Sign-up to receive the latest news and ratings for Renovacor and its competitors with MarketBeat's FREE daily newsletter.


Renovacor logo

About Renovacor

Renovacor Inc. is an early?stage biotechnology company developing adeno-associated virus based gene therapies for devastating cardiovascular and central nervous system diseases resulting from BAG3 gene variants. Renovacor Inc., formerly known as Chardan Healthcare Acquisition 2 Corp., is based in NEW YORK.

Headlines

Renovacor Inc (NYSE:RCOR) Major Shareholder Rtw Investments, Lp Buys 44,440 Shares
January 20, 2022 |  insidertrades.com
Rtw Investments, Lp Purchases 1,950 Shares of Renovacor Inc (NYSE:RCOR) Stock
January 14, 2022 |  insidertrades.com
Renovacor Inc (NYSE:RCOR) Major Shareholder Rtw Investments, Lp Purchases 150,723 Shares
January 14, 2022 |  insidertrades.com
Renovacor Inc (NYSE:RCOR) Major Shareholder Rtw Investments, Lp Buys 100,195 Shares
January 6, 2022 |  insidertrades.com
Inhibikase Therapeutics (NYSE:IKT) & Renovacor (NYSE:RCOR) Head to Head Contrast
January 19, 2022 |  americanbankingnews.com
Renovacor to Participate in a Panel Presentation at the 11th Annual LifeSci Partners Corporate Access Event
January 3, 2022 |  finance.yahoo.com
Renovacor Insider Makes $1.4M Stock Purchase
November 9, 2021 |  benzinga.com
Renovacor to Present at the Chardan Virtual 5th Annual Genetic Medicines Conference
October 14, 2021 |  finance.yahoo.com
Renovacor Announces the Appointment of Kumar Dhanasekharan, Ph.D., as Senior Vice President of Technical Operations
October 14, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSE:RCOR
Previous Symbol
CUSIP
N/A
CIK
1799850
Web
renovacor.com
Phone
610-424-2650
Fax
N/A
Employees
2
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.46 per share
Price / Book
13.96

Profitability

EPS (Most Recent Fiscal Year)
N/A
Net Income
$-780 thousand
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-9.15%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
23.86
Quick Ratio
23.86

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
17,256,000
Free Float
N/A
Market Cap
$110.78 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/15/2021
Today
1/28/2022
Next Earnings (Estimated)
3/02/2022
Fiscal Year End
12/31/2022

MarketRank™

Overall MarketRank™

2.20 out of 5 stars

Medical Sector

402nd out of 1,417 stocks

Biological Products, Except Diagnostic Industry

62nd out of 207 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.0 5 -4 -3 -2 -1 -












Renovacor (NYSE:RCOR) Frequently Asked Questions

Is Renovacor a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Renovacor in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Renovacor stock.
View analyst ratings for Renovacor or view top-rated stocks.

When is Renovacor's next earnings date?

Renovacor is scheduled to release its next quarterly earnings announcement on Wednesday, March 2nd 2022.
View our earnings forecast for Renovacor.

How were Renovacor's earnings last quarter?

Renovacor Inc (NYSE:RCOR) posted its quarterly earnings results on Monday, November, 15th. The company reported ($0.54) earnings per share (EPS) for the quarter.
View Renovacor's earnings history.

What price target have analysts set for RCOR?

2 brokers have issued 12 month price objectives for Renovacor's stock. Their forecasts range from $20.00 to $22.00. On average, they expect Renovacor's stock price to reach $21.00 in the next twelve months. This suggests a possible upside of 227.1% from the stock's current price.
View analysts' price targets for Renovacor or view top-rated stocks among Wall Street analysts.

What is Renovacor's stock symbol?

Renovacor trades on the New York Stock Exchange (NYSE) under the ticker symbol "RCOR."

How do I buy shares of Renovacor?

Shares of RCOR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Renovacor's stock price today?

One share of RCOR stock can currently be purchased for approximately $6.42.

How much money does Renovacor make?

Renovacor has a market capitalization of $110.78 million.

How many employees does Renovacor have?

Renovacor employs 2 workers across the globe.

What is Renovacor's official website?

The official website for Renovacor is renovacor.com.

Where are Renovacor's headquarters?

Renovacor is headquartered at 17 STATE STREET 21 FLOOR, NEW YORK NY, 10004.

How can I contact Renovacor?

Renovacor's mailing address is 17 STATE STREET 21 FLOOR, NEW YORK NY, 10004. The company can be reached via phone at 610-424-2650 or via email at [email protected].


This page was last updated on 1/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.